DE1079059B - Verfahren zur Herstellung von 1-(tert.-Aminoaethyl)-2-benzyl-benzimidazolen - Google Patents
Verfahren zur Herstellung von 1-(tert.-Aminoaethyl)-2-benzyl-benzimidazolenInfo
- Publication number
 - DE1079059B DE1079059B DEC17630A DEC0017630A DE1079059B DE 1079059 B DE1079059 B DE 1079059B DE C17630 A DEC17630 A DE C17630A DE C0017630 A DEC0017630 A DE C0017630A DE 1079059 B DE1079059 B DE 1079059B
 - Authority
 - DE
 - Germany
 - Prior art keywords
 - group
 - alkyl
 - benzyl
 - radical
 - benzimidazole
 - Prior art date
 - Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
 - Pending
 
Links
- 238000000034 method Methods 0.000 title claims description 12
 - 238000002360 preparation method Methods 0.000 title claims description 5
 - LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 25
 - -1 alkyl radical Chemical class 0.000 claims description 22
 - 125000000217 alkyl group Chemical group 0.000 claims description 12
 - 150000003839 salts Chemical class 0.000 claims description 11
 - 150000001875 compounds Chemical class 0.000 claims description 10
 - 150000003254 radicals Chemical class 0.000 claims description 10
 - 229910052739 hydrogen Inorganic materials 0.000 claims description 7
 - 239000001257 hydrogen Substances 0.000 claims description 7
 - 150000002148 esters Chemical class 0.000 claims description 6
 - UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 5
 - 125000003545 alkoxy group Chemical group 0.000 claims description 4
 - 125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 claims description 4
 - 125000003396 thiol group Chemical group [H]S* 0.000 claims description 4
 - 125000004414 alkyl thio group Chemical group 0.000 claims description 3
 - 238000006798 ring closing metathesis reaction Methods 0.000 claims description 3
 - NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 2
 - QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 2
 - 125000001589 carboacyl group Chemical group 0.000 claims description 2
 - 125000005843 halogen group Chemical group 0.000 claims description 2
 - 125000005842 heteroatom Chemical group 0.000 claims description 2
 - 229910052760 oxygen Inorganic materials 0.000 claims description 2
 - 239000001301 oxygen Substances 0.000 claims description 2
 - 229910052717 sulfur Chemical group 0.000 claims description 2
 - 239000011593 sulfur Chemical group 0.000 claims description 2
 - 125000001302 tertiary amino group Chemical group 0.000 claims 2
 - 150000007514 bases Chemical class 0.000 claims 1
 - 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 claims 1
 - 125000002768 hydroxyalkyl group Chemical group 0.000 claims 1
 - ODUCDPQEXGNKDN-UHFFFAOYSA-N nitroxyl Chemical compound O=N ODUCDPQEXGNKDN-UHFFFAOYSA-N 0.000 claims 1
 - VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 53
 - XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 49
 - HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 29
 - 239000000243 solution Substances 0.000 description 25
 - RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 23
 - CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 18
 - HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
 - 239000000203 mixture Substances 0.000 description 14
 - QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 12
 - 239000002253 acid Substances 0.000 description 12
 - 239000003921 oil Substances 0.000 description 11
 - 238000003756 stirring Methods 0.000 description 11
 - QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 10
 - 238000001704 evaporation Methods 0.000 description 9
 - 229910052943 magnesium sulfate Inorganic materials 0.000 description 9
 - 235000019341 magnesium sulphate Nutrition 0.000 description 9
 - CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 8
 - 239000002585 base Substances 0.000 description 8
 - 238000006243 chemical reaction Methods 0.000 description 8
 - 230000008020 evaporation Effects 0.000 description 8
 - 239000007858 starting material Substances 0.000 description 8
 - 239000003929 acidic solution Substances 0.000 description 7
 - VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 6
 - OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
 - 230000001476 alcoholic effect Effects 0.000 description 6
 - 235000011114 ammonium hydroxide Nutrition 0.000 description 6
 - 238000002844 melting Methods 0.000 description 6
 - 230000008018 melting Effects 0.000 description 6
 - OSDZHDOKXGSWOD-UHFFFAOYSA-N nitroxyl;hydrochloride Chemical compound Cl.O=N OSDZHDOKXGSWOD-UHFFFAOYSA-N 0.000 description 6
 - 239000011541 reaction mixture Substances 0.000 description 6
 - 229960000583 acetic acid Drugs 0.000 description 5
 - 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 5
 - ZVVWZNFSMIFGEP-UHFFFAOYSA-N 2-(4-ethoxyphenyl)acetic acid Chemical compound CCOC1=CC=C(CC(O)=O)C=C1 ZVVWZNFSMIFGEP-UHFFFAOYSA-N 0.000 description 4
 - 150000007513 acids Chemical class 0.000 description 4
 - 150000001556 benzimidazoles Chemical class 0.000 description 4
 - 239000002026 chloroform extract Substances 0.000 description 4
 - 239000000284 extract Substances 0.000 description 4
 - ODZPKZBBUMBTMG-UHFFFAOYSA-N sodium amide Chemical compound [NH2-].[Na+] ODZPKZBBUMBTMG-UHFFFAOYSA-N 0.000 description 4
 - XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
 - PQXBQWKKJUWNDI-UHFFFAOYSA-N 2-(4-ethoxyphenyl)acetonitrile Chemical compound CCOC1=CC=C(CC#N)C=C1 PQXBQWKKJUWNDI-UHFFFAOYSA-N 0.000 description 3
 - UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
 - PAYRUJLWNCNPSJ-UHFFFAOYSA-N N-phenyl amine Natural products NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 3
 - MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
 - 229910021529 ammonia Inorganic materials 0.000 description 3
 - 239000007864 aqueous solution Substances 0.000 description 3
 - 239000003054 catalyst Substances 0.000 description 3
 - 239000013078 crystal Substances 0.000 description 3
 - 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
 - 239000012362 glacial acetic acid Substances 0.000 description 3
 - RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
 - NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
 - 239000002904 solvent Substances 0.000 description 3
 - RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
 - FQQSRELBEQHDMQ-UHFFFAOYSA-N 2-(4-methylphenyl)-2-sulfanylacetonitrile Chemical compound CC1=CC=C(C(S)C#N)C=C1 FQQSRELBEQHDMQ-UHFFFAOYSA-N 0.000 description 2
 - XQXPVVBIMDBYFF-UHFFFAOYSA-N 4-hydroxyphenylacetic acid Chemical compound OC(=O)CC1=CC=C(O)C=C1 XQXPVVBIMDBYFF-UHFFFAOYSA-N 0.000 description 2
 - CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
 - NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
 - DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
 - OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
 - AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
 - MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 2
 - NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
 - QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
 - 229910052784 alkaline earth metal Inorganic materials 0.000 description 2
 - 238000009835 boiling Methods 0.000 description 2
 - 238000005660 chlorination reaction Methods 0.000 description 2
 - XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
 - 238000001035 drying Methods 0.000 description 2
 - 239000000706 filtrate Substances 0.000 description 2
 - 150000003840 hydrochlorides Chemical class 0.000 description 2
 - 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
 - 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
 - 229910052751 metal Inorganic materials 0.000 description 2
 - 239000002184 metal Substances 0.000 description 2
 - 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
 - DTUQWGWMVIHBKE-UHFFFAOYSA-N phenylacetaldehyde Chemical compound O=CCC1=CC=CC=C1 DTUQWGWMVIHBKE-UHFFFAOYSA-N 0.000 description 2
 - WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical compound OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 description 2
 - SUSQOBVLVYHIEX-UHFFFAOYSA-N phenylacetonitrile Chemical compound N#CCC1=CC=CC=C1 SUSQOBVLVYHIEX-UHFFFAOYSA-N 0.000 description 2
 - BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
 - 150000003335 secondary amines Chemical class 0.000 description 2
 - 239000011734 sodium Substances 0.000 description 2
 - 229910052708 sodium Inorganic materials 0.000 description 2
 - 239000007787 solid Substances 0.000 description 2
 - 239000000725 suspension Substances 0.000 description 2
 - JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
 - 239000000052 vinegar Substances 0.000 description 2
 - 235000021419 vinegar Nutrition 0.000 description 2
 - AYKYOOPFBCOXSL-UHFFFAOYSA-N (4-hydroxyphenyl)acetonitrile Chemical compound OC1=CC=C(CC#N)C=C1 AYKYOOPFBCOXSL-UHFFFAOYSA-N 0.000 description 1
 - BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
 - VWVZFHRDLPHBEG-UHFFFAOYSA-N 1-(chloromethyl)-4-methylsulfanylbenzene Chemical compound CSC1=CC=C(CCl)C=C1 VWVZFHRDLPHBEG-UHFFFAOYSA-N 0.000 description 1
 - NWESJZZPAJGHRZ-UHFFFAOYSA-N 1-chloro-4-methyl-2-nitrobenzene Chemical compound CC1=CC=C(Cl)C([N+]([O-])=O)=C1 NWESJZZPAJGHRZ-UHFFFAOYSA-N 0.000 description 1
 - HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 description 1
 - PACGLQCRGWFBJH-UHFFFAOYSA-N 2-(4-methoxyphenyl)acetonitrile Chemical compound COC1=CC=C(CC#N)C=C1 PACGLQCRGWFBJH-UHFFFAOYSA-N 0.000 description 1
 - LXQLRTQQYMBXIR-UHFFFAOYSA-N 2-[(4-ethoxyphenyl)methyl]-5,6-dimethyl-1h-benzimidazole Chemical compound C1=CC(OCC)=CC=C1CC1=NC2=CC(C)=C(C)C=C2N1 LXQLRTQQYMBXIR-UHFFFAOYSA-N 0.000 description 1
 - 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 description 1
 - YMDNODNLFSHHCV-UHFFFAOYSA-N 2-chloro-n,n-diethylethanamine Chemical compound CCN(CC)CCCl YMDNODNLFSHHCV-UHFFFAOYSA-N 0.000 description 1
 - QYIGFZOHYGYBLX-UHFFFAOYSA-N 2-phenyl-2-sulfanylacetic acid Chemical compound OC(=O)C(S)C1=CC=CC=C1 QYIGFZOHYGYBLX-UHFFFAOYSA-N 0.000 description 1
 - SLRMQYXOBQWXCR-UHFFFAOYSA-N 2154-56-5 Chemical group [CH2]C1=CC=CC=C1 SLRMQYXOBQWXCR-UHFFFAOYSA-N 0.000 description 1
 - ITPDIGZAMXKBCF-UHFFFAOYSA-N 3h-benzimidazol-5-ylmethanol Chemical compound OCC1=CC=C2NC=NC2=C1 ITPDIGZAMXKBCF-UHFFFAOYSA-N 0.000 description 1
 - DGRGLKZMKWPMOH-UHFFFAOYSA-N 4-methylbenzene-1,2-diamine Chemical compound CC1=CC=C(N)C(N)=C1 DGRGLKZMKWPMOH-UHFFFAOYSA-N 0.000 description 1
 - 101100322245 Caenorhabditis elegans des-2 gene Proteins 0.000 description 1
 - OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
 - OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
 - WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
 - FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
 - 241001072332 Monia Species 0.000 description 1
 - AFBPFSWMIHJQDM-UHFFFAOYSA-N N-methylaniline Chemical compound CNC1=CC=CC=C1 AFBPFSWMIHJQDM-UHFFFAOYSA-N 0.000 description 1
 - 239000007868 Raney catalyst Substances 0.000 description 1
 - NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 1
 - 229910000564 Raney nickel Inorganic materials 0.000 description 1
 - 241000158147 Sator Species 0.000 description 1
 - KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
 - PLOSSHSFATUNTF-UHFFFAOYSA-N [K]C1=CC=CC=C1 Chemical compound [K]C1=CC=CC=C1 PLOSSHSFATUNTF-UHFFFAOYSA-N 0.000 description 1
 - 238000010521 absorption reaction Methods 0.000 description 1
 - 230000002378 acidificating effect Effects 0.000 description 1
 - 150000001298 alcohols Chemical class 0.000 description 1
 - 239000003513 alkali Substances 0.000 description 1
 - 150000001342 alkaline earth metals Chemical class 0.000 description 1
 - 230000029936 alkylation Effects 0.000 description 1
 - 238000005804 alkylation reaction Methods 0.000 description 1
 - BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
 - 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
 - 150000001408 amides Chemical class 0.000 description 1
 - 125000003277 amino group Chemical group 0.000 description 1
 - 229940035676 analgesics Drugs 0.000 description 1
 - 239000000730 antalgic agent Substances 0.000 description 1
 - YTLQFZVCLXFFRK-UHFFFAOYSA-N bendazol Chemical class N=1C2=CC=CC=C2NC=1CC1=CC=CC=C1 YTLQFZVCLXFFRK-UHFFFAOYSA-N 0.000 description 1
 - 229910052791 calcium Inorganic materials 0.000 description 1
 - 239000011575 calcium Substances 0.000 description 1
 - 229910052799 carbon Inorganic materials 0.000 description 1
 - 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
 - 239000012876 carrier material Substances 0.000 description 1
 - 239000007795 chemical reaction product Substances 0.000 description 1
 - 239000003795 chemical substances by application Substances 0.000 description 1
 - 238000001816 cooling Methods 0.000 description 1
 - 239000010779 crude oil Substances 0.000 description 1
 - 239000003085 diluting agent Substances 0.000 description 1
 - VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 description 1
 - 229940079593 drug Drugs 0.000 description 1
 - 239000003814 drug Substances 0.000 description 1
 - 230000032050 esterification Effects 0.000 description 1
 - 238000005886 esterification reaction Methods 0.000 description 1
 - 239000012259 ether extract Substances 0.000 description 1
 - LBAQSKZHMLAFHH-UHFFFAOYSA-N ethoxyethane;hydron;chloride Chemical compound Cl.CCOCC LBAQSKZHMLAFHH-UHFFFAOYSA-N 0.000 description 1
 - 239000002024 ethyl acetate extract Substances 0.000 description 1
 - URYAVPPYTHJURP-UHFFFAOYSA-N ethyl benzoate;hydrochloride Chemical compound Cl.CCOC(=O)C1=CC=CC=C1 URYAVPPYTHJURP-UHFFFAOYSA-N 0.000 description 1
 - 125000004494 ethyl ester group Chemical group 0.000 description 1
 - 125000000031 ethylamino group Chemical group [H]C([H])([H])C([H])([H])N([H])[*] 0.000 description 1
 - 238000000605 extraction Methods 0.000 description 1
 - 238000001914 filtration Methods 0.000 description 1
 - 239000007789 gas Substances 0.000 description 1
 - 229940093915 gynecological organic acid Drugs 0.000 description 1
 - 150000004678 hydrides Chemical class 0.000 description 1
 - 150000002430 hydrocarbons Chemical class 0.000 description 1
 - 150000004679 hydroxides Chemical class 0.000 description 1
 - 150000002463 imidates Chemical class 0.000 description 1
 - 229910003480 inorganic solid Inorganic materials 0.000 description 1
 - 150000002500 ions Chemical class 0.000 description 1
 - 239000007788 liquid Substances 0.000 description 1
 - 229910052744 lithium Inorganic materials 0.000 description 1
 - 239000012280 lithium aluminium hydride Substances 0.000 description 1
 - 229910052749 magnesium Inorganic materials 0.000 description 1
 - 239000011777 magnesium Substances 0.000 description 1
 - 239000001630 malic acid Substances 0.000 description 1
 - 235000011090 malic acid Nutrition 0.000 description 1
 - 238000004519 manufacturing process Methods 0.000 description 1
 - 229940098779 methanesulfonic acid Drugs 0.000 description 1
 - 150000007522 mineralic acids Chemical class 0.000 description 1
 - 229940035363 muscle relaxants Drugs 0.000 description 1
 - 239000003158 myorelaxant agent Substances 0.000 description 1
 - UDGSVBYJWHOHNN-UHFFFAOYSA-N n',n'-diethylethane-1,2-diamine Chemical compound CCN(CC)CCN UDGSVBYJWHOHNN-UHFFFAOYSA-N 0.000 description 1
 - 150000007524 organic acids Chemical class 0.000 description 1
 - 235000005985 organic acids Nutrition 0.000 description 1
 - 235000006408 oxalic acid Nutrition 0.000 description 1
 - HIJDQYZZPATXAO-UHFFFAOYSA-N palladium hydrochloride Chemical compound Cl.[Pd] HIJDQYZZPATXAO-UHFFFAOYSA-N 0.000 description 1
 - 239000003208 petroleum Substances 0.000 description 1
 - 239000000825 pharmaceutical preparation Substances 0.000 description 1
 - 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
 - 229940100595 phenylacetaldehyde Drugs 0.000 description 1
 - 229960003424 phenylacetic acid Drugs 0.000 description 1
 - 239000003279 phenylacetic acid Substances 0.000 description 1
 - NHKJPPKXDNZFBJ-UHFFFAOYSA-N phenyllithium Chemical compound [Li]C1=CC=CC=C1 NHKJPPKXDNZFBJ-UHFFFAOYSA-N 0.000 description 1
 - 229910052697 platinum Inorganic materials 0.000 description 1
 - NNFCIKHAZHQZJG-UHFFFAOYSA-N potassium cyanide Chemical compound [K+].N#[C-] NNFCIKHAZHQZJG-UHFFFAOYSA-N 0.000 description 1
 - LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
 - 239000000843 powder Substances 0.000 description 1
 - 239000000047 product Substances 0.000 description 1
 - 235000019260 propionic acid Nutrition 0.000 description 1
 - IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
 - 238000001953 recrystallisation Methods 0.000 description 1
 - QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
 - 239000012312 sodium hydride Substances 0.000 description 1
 - 229910000104 sodium hydride Inorganic materials 0.000 description 1
 - KKCBUQHMOMHUOY-UHFFFAOYSA-N sodium oxide Chemical compound [O-2].[Na+].[Na+] KKCBUQHMOMHUOY-UHFFFAOYSA-N 0.000 description 1
 - 229910001948 sodium oxide Inorganic materials 0.000 description 1
 - 239000000126 substance Substances 0.000 description 1
 - 150000003460 sulfonic acids Chemical class 0.000 description 1
 - 230000001225 therapeutic effect Effects 0.000 description 1
 - 230000000699 topical effect Effects 0.000 description 1
 
Classifications
- 
        
- C—CHEMISTRY; METALLURGY
 - C07—ORGANIC CHEMISTRY
 - C07D—HETEROCYCLIC COMPOUNDS
 - C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
 - C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
 - C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
 - C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
 - C07D235/12—Radicals substituted by oxygen atoms
 
 - 
        
- A—HUMAN NECESSITIES
 - A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
 - A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
 - A61K31/00—Medicinal preparations containing organic active ingredients
 
 - 
        
- C—CHEMISTRY; METALLURGY
 - C07—ORGANIC CHEMISTRY
 - C07D—HETEROCYCLIC COMPOUNDS
 - C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
 - C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
 - C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
 - C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
 
 
Landscapes
- Chemical & Material Sciences (AREA)
 - Organic Chemistry (AREA)
 - Health & Medical Sciences (AREA)
 - Medicinal Chemistry (AREA)
 - Pharmacology & Pharmacy (AREA)
 - Epidemiology (AREA)
 - Life Sciences & Earth Sciences (AREA)
 - Animal Behavior & Ethology (AREA)
 - General Health & Medical Sciences (AREA)
 - Public Health (AREA)
 - Veterinary Medicine (AREA)
 - Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
 
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title | 
|---|---|---|---|
| CH5157657A CH362696A (de) | 1957-10-14 | 1957-10-14 | Verfahren zur Herstellung neuer Benzimidazole | 
Publications (1)
| Publication Number | Publication Date | 
|---|---|
| DE1079059B true DE1079059B (de) | 1960-04-07 | 
Family
ID=4517674
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date | 
|---|---|---|---|
| DEC17630A Pending DE1079059B (de) | 1957-10-14 | 1958-10-07 | Verfahren zur Herstellung von 1-(tert.-Aminoaethyl)-2-benzyl-benzimidazolen | 
Country Status (6)
| Country | Link | 
|---|---|
| BE (1) | BE571984A (pm) | 
| CH (1) | CH362696A (pm) | 
| DE (1) | DE1079059B (pm) | 
| FR (1) | FR1214219A (pm) | 
| GB (1) | GB874588A (pm) | 
| NL (2) | NL232213A (pm) | 
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title | 
|---|---|---|---|---|
| WO2013101911A3 (en) * | 2011-12-28 | 2013-08-22 | Allergan, Inc. | Benzimidazole derivatives as selective blockers of persistent sodium current | 
- 
        0
        
- NL NL106895D patent/NL106895C/xx active
 - NL NL232213D patent/NL232213A/xx unknown
 - BE BE571984D patent/BE571984A/xx unknown
 
 - 
        1957
        
- 1957-10-14 CH CH5157657A patent/CH362696A/de unknown
 
 - 
        1958
        
- 1958-10-07 DE DEC17630A patent/DE1079059B/de active Pending
 - 1958-10-09 FR FR1214219D patent/FR1214219A/fr not_active Expired
 - 1958-10-14 GB GB3284658A patent/GB874588A/en not_active Expired
 
 
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title | 
|---|---|---|---|---|
| WO2013101911A3 (en) * | 2011-12-28 | 2013-08-22 | Allergan, Inc. | Benzimidazole derivatives as selective blockers of persistent sodium current | 
| US8859780B2 (en) | 2011-12-28 | 2014-10-14 | Allergan, Inc. | Benzimidazole derivatives as selective blockers of persistent sodium current | 
| US9540332B2 (en) | 2011-12-28 | 2017-01-10 | Allergan, Inc. | Benzimidazole derivatives as selective blockers of persistent sodium current | 
Also Published As
| Publication number | Publication date | 
|---|---|
| NL232213A (pm) | |
| FR1214219A (fr) | 1960-04-07 | 
| BE571984A (pm) | |
| GB874588A (en) | 1961-08-10 | 
| NL106895C (pm) | |
| CH362696A (de) | 1962-06-30 | 
Similar Documents
| Publication | Publication Date | Title | 
|---|---|---|
| DE1670849B2 (de) | Verfahren zur herstellung von 8-acylamino-1,2,3,4-tetrahydroisochinolinen | |
| DE1620450C3 (de) | 1 - (2- Hydroxybenzyl) -2-piperazinomethylbenzimidazole, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel | |
| DE1595920A1 (de) | 4-(omega-Piperazinoalkyl)-pyrazole,ihre Salze und Verfahren zu ihrer Herstellung | |
| DE1695780A1 (de) | Verfahren zur Herstellung von neuen N-Alkyl-3,1-benzoxain-2-onen | |
| DE1802297C3 (de) | Isopropylaminderivate und Verfahren zu ihrer Herstellung | |
| DE1079059B (de) | Verfahren zur Herstellung von 1-(tert.-Aminoaethyl)-2-benzyl-benzimidazolen | |
| DE1670478A1 (de) | Verfahren zur Herstellung von Derivaten des alpha-Piperazino-phenylacetonitrils | |
| DE936747C (de) | Verfahren zur Herstellung von neuen Pyrimidinderivaten und deren Salzen | |
| DE2656227C2 (de) | Basisch alkylierte Diphenyldisulfid-2,2'-biscarbonsäureamide, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel | |
| DE2156501A1 (de) | Verfahren zur herstellung von 5,6gamma-pyridonderivaten | |
| DE1078131B (de) | Verfahren zur Herstellung neuer Benzimidazole | |
| DE2029185A1 (en) | 2-azaquinolizidine derivs and salts neurotropic and anti - -histamine agents synthesis | |
| DE1018869B (de) | Verfahren zur Herstellung von Aminoalkylpurinderivaten | |
| AT209338B (de) | Verfahren zur Herstellung neuer Benzimidazole | |
| AT250338B (de) | Verfahren zur Herstellung neuer, basischer Derivate von substituierten Benzofuran-2-carbonsäuren und deren Salzen | |
| AT208854B (de) | Verfahren zur Herstellung neuer Benzimidazole | |
| DE1643265C3 (de) | Kernsubstituierte 2-Aminomethylbenzhydrole, Verfahren zu deren Herstellung und Arzneimittel auf der Basis dieser Verbindungen | |
| DE1445648C (de) | Homopiperazindenvate | |
| AT210417B (de) | Verfahren zur Herstellung neuer Benzimidazole | |
| AT212326B (de) | Verfahren zur Herstellung von neuen, basisch substituierten Azepinderivaten | |
| AT222117B (de) | Verfahren zur Herstellung neuer Azabenz-imidazole | |
| AT235280B (de) | Verfahren zur Herstellung neuer Indolderivate | |
| AT205038B (de) | Verfahren zur Herstellung neuer, in 10-Stellung substituierter 11-Oxo-dibenzo-[b, f]-thia-[1]-aza-[4]-cycloheptadien-[2,6]-Verbindungen | |
| AT205968B (de) | Verfahren zur Herstellung neuer Benzimidazole | |
| AT214917B (de) | Verfahren zur Herstellung neuer Benzimidazole |